'김갑성' 기자의 전체기사
-
New Public Perception Survey Highlights Fragmented Cancer…
YouGov survey finds strong belief in value of early detection (76%) but low screening uptake (13%) Confidence in coordinated care (34%) and in 'one-stop' care (36%) among the lowest in Southeast Asia Strongest regional demand for advanced technology in follow-up care and recurrence detection (58%) MANILA, Philippines, Sept. 10, 2025 -- Public perceptions of cancer care in the Philippines show critical gaps across the pathway from screening and diagnosis through to treatment and survivorship, according to new research commissioned by Siemens Healthineers. &nb
- 김갑성 기자
- 2025-09-10 14:00
-
Taiwanese Women's Shifting Views on Childbirth: Autonomy…
TAIPEI, Sept. 10, 2025 -- The attitude of Taiwanese women toward childbirth is rapidly changing. With the legalization of same-sex marriage, rising educational attainment among female, and increased participation in the workforce, the traditional model of "marriage necessarily leading to childbirth" is no longer the norm. According to data from the Ministry of the Interior, the average age of first-time mother in Taiwan has exceeded 33, and the total fertility rate has fallen to the lowest in the world. Many women are choosing to delay childbirth, have fewer children, or forgo havin
- 김갑성 기자
- 2025-09-10 13:53
-
Leaft Foods、Lacto Japanと提携し、革新的なリーフ・ルビスコ・プロテイ…
[ 메디채널 김갑성 기자 ] 戦略的パートナーシップにより、Lacto の市場専門知識を活用し、日本のイノベーション主導型食品メーカーに次世代プロテインを提供 ニュージーランド・ロールストンおよび東京、2025年9月10日 -- Leaft Foods緑葉から直接抽出した地球上で最も豊富なタンパク質を活用し、業界をリードする製品を生み出している企業が、本日、特殊食品原料の主要なディストリビューター兼生産者である企業との[ 메디채널 김갑성 기자 ] 戦略的パートナーシップLacto Japan Co., Ltd.を発表しました。この協業により、Leaft の画期的なルビスコ・プロテイン・アイソレートの商業化が、日本の高度な食品製造業界において加速されることとなります。 Leaft のRubisco Protein Isolateは、タンパク質業界におけるパラダイムシフトを示しています。Rubisco の特筆すべき点は、栄養面と機能面の特性を兼ね備え、ホエイプロテインなどの動物由来タンパク質を凌駕していることです。Leaf Rubiscoは、ホエイプロテインを上回るアミノ酸プロファイルを提供し、タンパク質栄養における新たなゴールドスタンダードを確立します。 卓越した栄養プロファイルに加え、Leaf Rubiscoは優れた食品機能
- 김갑성 기자
- 2025-09-10 13:20
-
New Public Perception Survey Highlights Fragmented Cancer…
YouGov survey finds strong belief in value of early detection (88%) but under half screened (40%) 84% of respondents aware post-treatment care exists, 55% lack understanding of what it involves Findings show confidence in "one-stop" cancer services and cautious optimism for digital innovation BANGKOK , Sept. 10, 2025 -- Public perceptions of cancer care in Thailand show critical gaps across the pathway from screening and diagnosis through to treatment and survivorship, according to new research commissioned by Siemens Healthineers. Bridgi
- 김갑성 기자
- 2025-09-10 11:39
-
New Public Perception Survey Highlights Fragmented Cancer…
YouGov survey finds belief in value of early detection (65%) but very low screening uptake (8%) 76% of respondents aware post-treatment care exists, 58% lack understanding of what it involves Confidence in coordinated care (39%) and in 'one-stop' care (31%) among lowest in Southeast Asia JAKARTA, Indonesia, Sept. 10, 2025 -- Public perceptions of cancer care in Indonesia show critical gaps across the pathway from screening and diagnosis through to treatment and survivorship, according to new research commissioned by Siemens Healthineers. Bridging t
- 김갑성 기자
- 2025-09-10 11:24
-
Korea Health Functional Food Association to Showcase Glo…
[ 메디채널 김갑성 기자 ] Operating a Korea Health Functional Food Promotional Booth under the 'K-Health W.A.V.E' slogan Introduces Korea's system, research achievements, and new technologies through seminars featuring the Ministry of Food and Drug Safety and member companies SEOUL, South Korea, Sept. 10, 2025 -- The Korea Health Functional Food Association (KHFF) will participate in "Vitafoods Asia 2025," to be held from September 17 to 19 at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand, and will showcase the excellence and technological capabilities
- 김갑성 기자
- 2025-09-10 11:00
-
ImmVira Announces First-in-Human Data of Engineered Exoso…
SUZHOU, China, Sept. 10, 2025 -- ImmVira Group ("ImmVira" or the "Company") recently announced that its lead engineered exosome candidate, MVR-EX105 ("EX105") is featured in a poster presentation at the 2025 Annual Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Founded in 1995, IFSO is a leading international professional organization comprising bariatric and metabolic surgeons and integrated health professionals worldwide. It is dedicated to providing optimal surgical care for obesity, improving the tre
- 김갑성 기자
- 2025-09-10 10:49
-
Cadonilimab(PD-1/CTLA-4) plus Pulocimab (VEGFR-2) Combinati…
HONG KONG, Sept. 10, 2025 -- Akeso Inc. (9926.HK) announced that data from a Phase Ib/II clinical study evaluating the combination of cadonilimab and pulocimab (an anti-VEGFR-2 antibody) in patients with immunotherapy (IO)-resistant NSCLC were presented in a Mini Oral session at the 2025 World Conference on Lung Cancer (WCLC). This marks the first clinical data release for cadonilimab in IO-resistant lung cancer. The cadonilimab combination therapy for advanced squamous non-small cell lung cancer (NSCLC) progressing after PD-(L)1 inhibitor treatment, has previously received Breakthrough Thera
- 김갑성 기자
- 2025-09-10 10:40
-
New Public Perception Survey Highlights Fragmented Cancer…
YouGov survey finds strong belief in value of early detection (79%) but low screening uptake (25%) 82% of respondents aware post-treatment care exists, 55% lack understanding of what it involves Findings show confidence in "one-stop" cancer services and openness to digital innovation KUALA LUMPUR, Malaysia, Sept. 10, 2025 -- Public perceptions of cancer care in Malaysia show critical gaps across the pathway from screening and diagnosis through to treatment and survivorship, according to new research commissioned by Siemens Healthineers. B
- 김갑성 기자
- 2025-09-10 09:00
-
Allianz Partners appoints Okan Özdemir as its new Chief Offic…
PARIS, Sept. 10, 2025 -- Allianz Partners, a global leader in insurance and assistance services, is pleased to announce the appointment of Okan Özdemir as its new Chief Officer for Health and Board Member, effective September 1, 2025. In this role, Okan will report directly to Allianz Partners CEO Tomas Kunzmann. Okan Özdemir joins Allianz Partners from Allianz Türkiye, where he served as Chief Health Officer and Executive Board Member since 2019. With over 24 years of strong leadership at Allianz in a number of strategic roles including Chief Mark
- 김갑성 기자
- 2025-09-10 09:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-19_SUN
- Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting 15:00
- Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia 14:00
- From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use 13:00
- 내면의 조화를 발견하세요: '원더풀 인도네시아 웰니스 페스티벌 2025' 개최 01:50
- 제2회 마나르 아부다비 출품 작가 명단 공개 00:48
- 중국-피지 어업 협력, 섬나라 경제 활력 끌어올리다 00:00
2025-10-18_SAT
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 19일 16시 40분